Ivim Health

About Ivim Health

Ivim Health is the highest-scoring provider in our directory, and it earns that distinction through a combination of clinical excellence, transparency, and patient satisfaction that few competitors can match. Founded in 2021, the platform has rapidly scaled while maintaining the kind of quality markers — published clinical research, CoA testing, lab work, and dietitian access — that define best-in-class GLP-1 care.

Ivim offers both compounded semaglutide ($149/month) and compounded tirzepatide ($224/month), plus brand-name options like Ozempic, Wegovy, and Zepbound for patients who prefer FDA-approved formulations. Insurance is accepted alongside self-pay, making it accessible across different financial situations.

The clinical program is comprehensive. Every patient gets lab testing included, access to a registered dietitian, and ongoing medical support from providers who follow evidence-based protocols. Ivim has also published clinical research on their approach — a level of scientific transparency that’s virtually unheard of among telehealth GLP-1 providers.

Patient satisfaction metrics are exceptional: a 4.9 Trustpilot rating across 36,000+ reviews combined with an A+ BBB rating. That combination of volume, rating quality, and institutional trust is the strongest in our database by a significant margin.

Ivim provides a Certificate of Analysis for their compounded medications and maintains high trust and compliance transparency throughout their platform. The holistic approach — combining medication, lab monitoring, nutritional guidance, and ongoing clinical support — reflects the kind of integrated care model that produces the best long-term outcomes.

Ivim Health GLP-1 Medications

At a Glance